Kami Kim, MD
Infectious Disease · Tampa, FLNPI 1477638252
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,395 of the $5,716 with a category attached, or 76.9%. 4 manufacturers reported payments, led by Shionogi Inc at 44.1% of the total. 2025 is the largest year on record at $3,405, more than ten times the $63 reported in 2021.
Across 9 payments — averaging $635.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shionogi Inc$3K
- Regeneron$2K
- Biomerieux Inc$1K
- Angiodynamics, Inc.$116
Across 299 payments — averaging $7844.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$2.2M
- Pfizer$92K
- Dompe Farmaceutici S.p.a.$31K
- Astrazeneca UK Limited$27K
- AstraZeneca$25K
- Merck$3K
- plus $3K from 2 others
What the payments were for
- Consulting fees$4,39577%
- Travel & lodging$3456%
- Food & beverage$97617%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shionogi Inc | 1 | $2,520 |
| Regeneron | 3 | $1,938 |
| Biomerieux Inc | 4 | $1,143 |
| Angiodynamics, Inc. | 1 | $116 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,716 in reported general payments places this provider in the 80th percentile of 669 infectious disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Tampa
- Sally AlrabaaTampa$250K
- Beata CasanasTampa$227K
- Michael DunnTampa$45K
- Brahm SegalTampa$31K
- Margarita CancioTampa$23K
- Pamela NoelTampa$22K
- Lennox ArchibaldGainesville$2.1M
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
- Charlotte-Paige RolleOrlando$619K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.